{
  "DOI": "10.1186/s40246-020-00265-5",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-020-00265-5",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003e5-Methylcytosine (5mC) is considered as a common epigenetic modification that plays an important role in the regulation of gene expression. At the same time, 5-hydroxymethylcytosine (5hmC) has been found as an emerging modification of cytosine bases of recent years. Unlike 5mC, global 5hmC levels vary from tissues that have differential distribution both in mammalian tissues and in the genome. DNA hydroxymethylation is the process that 5mC oxidates into 5hmC with the catalysis of TET (ten-eleven translocation) enzymes. It is an essential option of DNA demethylation, which modulates gene expression by adjusting the DNA methylation level. Various factors can regulate the demethylation of DNA, such as environmental toxins and mental stress. In this review, we summarize the progress in the formation of 5hmC, and obtaining 5hmC in a cell-free DNA sample presents multiple advantages and challenges for the subject. Furthermore, the clinical potential for 5hmC modification in dealing with cancer early diagnosis, prognostic evaluation, and prediction of therapeutic effect is also mentioned.\u003c/jats:p\u003e",
  "alternative-id": [
    "265"
  ],
  "article-number": "15",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "18 February 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "22 April 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "6 May 2020"
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "Not applicable"
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Consent for publication was obtained from the participants."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The authors declare that there is no conflict of interest regarding the publication of this article."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0001-5470-0887",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Xu",
      "given": "Tianmin",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Gao",
      "given": "Haoyue",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2020,
        5,
        6
      ]
    ],
    "date-time": "2020-05-06T11:03:42Z",
    "timestamp": 1588763022000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        9,
        30
      ]
    ],
    "date-time": "2023-09-30T19:04:17Z",
    "timestamp": 1696100657000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        29
      ]
    ],
    "date-time": "2024-04-29T01:30:08Z",
    "timestamp": 1714354208624
  },
  "is-referenced-by-count": 30,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2020,
        5,
        6
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2020,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            5,
            6
          ]
        ],
        "date-time": "2020-05-06T00:00:00Z",
        "timestamp": 1588723200000
      }
    },
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            5,
            6
          ]
        ],
        "date-time": "2020-05-06T00:00:00Z",
        "timestamp": 1588723200000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-020-00265-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-020-00265-5/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-020-00265-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2020,
        5,
        6
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2020,
        5,
        6
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2020,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/j.gde.2017.03.015",
      "author": "AD Kelly",
      "doi-asserted-by": "publisher",
      "first-page": "68",
      "journal-title": "Curr Opin Genet Dev",
      "key": "265_CR1",
      "unstructured": "Kelly AD, Issa JJ. The promise of epigenetic therapy: reprogramming the cancer epigenome. Curr Opin Genet Dev. 2017;42:68–77.",
      "volume": "42",
      "year": "2017"
    },
    {
      "DOI": "10.1111/j.1399-0004.2011.01809.x",
      "author": "R Kanwal",
      "doi-asserted-by": "publisher",
      "first-page": "303",
      "issue": "4",
      "journal-title": "Clin Genet",
      "key": "265_CR2",
      "unstructured": "Kanwal R, Gupta S. Epigenetic modifications in cancer. Clin Genet. 2012;81(4):303–11.",
      "volume": "81",
      "year": "2012"
    },
    {
      "DOI": "10.1016/B978-0-12-391940-3.00005-6",
      "author": "L Shen",
      "doi-asserted-by": "publisher",
      "first-page": "93",
      "journal-title": "Methods Enzymol",
      "key": "265_CR3",
      "unstructured": "Shen L, Zhang Y. Enzymatic analysis of Tet proteins: key enzymes in the metabolism of DNA methylation. Methods Enzymol. 2012;512:93–105.",
      "volume": "512",
      "year": "2012"
    },
    {
      "DOI": "10.1126/science.1210597",
      "author": "S Ito",
      "doi-asserted-by": "publisher",
      "first-page": "1300",
      "issue": "6047",
      "journal-title": "Science.",
      "key": "265_CR4",
      "unstructured": "Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science. 2011;333(6047):1300–3.",
      "volume": "333",
      "year": "2011"
    },
    {
      "DOI": "10.1002/anie.201103899",
      "author": "T Pfaffeneder",
      "doi-asserted-by": "publisher",
      "first-page": "7008",
      "issue": "31",
      "journal-title": "Angew Chem Int Ed Engl",
      "key": "265_CR5",
      "unstructured": "Pfaffeneder T, Hackner B, Truss M, Munzel M, Muller M, Deiml CA, et al. The discovery of 5-formylcytosine in embryonic stem cell DNA. Angew Chem Int Ed Engl. 2011;50(31):7008–12.",
      "volume": "50",
      "year": "2011"
    },
    {
      "DOI": "10.1126/science.1210944",
      "author": "YF He",
      "doi-asserted-by": "publisher",
      "first-page": "1303",
      "issue": "6047",
      "journal-title": "Science.",
      "key": "265_CR6",
      "unstructured": "He YF, Li BZ, Li Z, Liu P, Wang Y, Tang Q, et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science. 2011;333(6047):1303–7.",
      "volume": "333",
      "year": "2011"
    },
    {
      "author": "LI Kroeze",
      "first-page": "144",
      "issue": "2",
      "journal-title": "Biochim Biophys Acta",
      "key": "265_CR7",
      "unstructured": "Kroeze LI, van der Reijden BA, Jansen JH. 5-Hydroxymethylcytosine: an epigenetic mark frequently deregulated in cancer. Biochim Biophys Acta. 2015;1855(2):144–54.",
      "volume": "1855",
      "year": "2015"
    },
    {
      "DOI": "10.1146/annurev-genet-102108-134205",
      "author": "JK Zhu",
      "doi-asserted-by": "publisher",
      "first-page": "143",
      "journal-title": "Annu Rev Genet",
      "key": "265_CR8",
      "unstructured": "Zhu JK. Active DNA demethylation mediated by DNA glycosylases. Annu Rev Genet. 2009;43:143–66.",
      "volume": "43",
      "year": "2009"
    },
    {
      "DOI": "10.1073/pnas.1310656110",
      "author": "H Huang",
      "doi-asserted-by": "publisher",
      "first-page": "11994",
      "issue": "29",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "265_CR9",
      "unstructured": "Huang H, Jiang X, Li Z, Li Y, Song CX, He C, et al. TET1 plays an essential oncogenic role in MLL-rearranged leukemia. Proc Natl Acad Sci U S A. 2013;110(29):11994–9.",
      "volume": "110",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.freeradbiomed.2016.11.038",
      "author": "A Klungland",
      "doi-asserted-by": "publisher",
      "first-page": "62",
      "journal-title": "Free Radic Biol Med",
      "key": "265_CR10",
      "unstructured": "Klungland A, Robertson AB. Oxidized C5-methyl cytosine bases in DNA: 5-Hydroxymethylcytosine; 5-formylcytosine; and 5-carboxycytosine. Free Radic Biol Med. 2017;107:62–8.",
      "volume": "107",
      "year": "2017"
    },
    {
      "DOI": "10.1371/journal.pone.0166575",
      "author": "DK Kranzhofer",
      "doi-asserted-by": "publisher",
      "issue": "11",
      "journal-title": "PLoS One",
      "key": "265_CR11",
      "unstructured": "Kranzhofer DK, Gilsbach R, Gruning BA, Backofen R, Nuhrenberg TG, Hein L. 5'-Hydroxymethylcytosine precedes loss of CpG methylation in enhancers and genes undergoing activation in cardiomyocyte maturation. PLoS One. 2016;11(11):e0166575.",
      "volume": "11",
      "year": "2016"
    },
    {
      "DOI": "10.1038/emm.2017.10",
      "author": "M Kim",
      "doi-asserted-by": "publisher",
      "issue": "4",
      "journal-title": "Exp Mol Med",
      "key": "265_CR12",
      "unstructured": "Kim M, Costello J. DNA methylation: an epigenetic mark of cellular memory. Exp Mol Med. 2017;49(4):e322.",
      "volume": "49",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.gpb.2018.06.002",
      "author": "J Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "187",
      "issue": "3",
      "journal-title": "Genomics Proteomics Bioinformatics",
      "key": "265_CR13",
      "unstructured": "Zhang J, Han X, Gao C, Xing Y, Qi Z, Liu R, et al. 5-Hydroxymethylome in circulating cell-free DNA as a potential biomarker for non-small-cell lung cancer. Genomics Proteomics Bioinformatics. 2018;16(3):187–99.",
      "volume": "16",
      "year": "2018"
    },
    {
      "DOI": "10.1038/cr.2017.106",
      "author": "CX Song",
      "doi-asserted-by": "publisher",
      "first-page": "1231",
      "issue": "10",
      "journal-title": "Cell Res",
      "key": "265_CR14",
      "unstructured": "Song CX, Yin S, Ma L, Wheeler A, Chen Y, Zhang Y, et al. 5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages. Cell Res. 2017;27(10):1231–42.",
      "volume": "27",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.aca.2018.08.035",
      "author": "T Shahal",
      "doi-asserted-by": "publisher",
      "first-page": "87",
      "journal-title": "Anal Chim Acta",
      "key": "265_CR15",
      "unstructured": "Shahal T, Koren O, Shefer G, Stern N, Ebenstein Y. Hypersensitive quantification of global 5-hydroxymethylcytosine by chemoenzymatic tagging. Anal Chim Acta. 2018;1038:87–96.",
      "volume": "1038",
      "year": "2018"
    },
    {
      "DOI": "10.1093/nar/gkz715",
      "author": "F Yu",
      "doi-asserted-by": "publisher",
      "first-page": "D40",
      "issue": "D1",
      "journal-title": "Nucleic Acids Res",
      "key": "265_CR16",
      "unstructured": "Yu F, Li K, Li S, Liu J, Zhang Y, Zhou M, et al. CFEA: a cell-free epigenome atlas in human diseases. Nucleic Acids Res. 2020;48(D1):D40–d4.",
      "volume": "48",
      "year": "2020"
    },
    {
      "DOI": "10.1159/000492917",
      "author": "J Fernandes Marques",
      "doi-asserted-by": "publisher",
      "first-page": "456",
      "issue": "6",
      "journal-title": "Acta Cytol",
      "key": "265_CR17",
      "unstructured": "Fernandes Marques J, Pereira Reis J, Fernandes G, Hespanhol V, Machado JC, Costa JL. Circulating tumor DNA: a step into the future of cancer management. Acta Cytol. 2019;63(6):456–65.",
      "volume": "63",
      "year": "2019"
    },
    {
      "DOI": "10.1039/C6CS00803H",
      "author": "Z Shen",
      "doi-asserted-by": "publisher",
      "first-page": "2038",
      "issue": "8",
      "journal-title": "Chem Soc Rev",
      "key": "265_CR18",
      "unstructured": "Shen Z, Wu A, Chen X. Current detection technologies for circulating tumor cells. Chem Soc Rev. 2017;46(8):2038–56.",
      "volume": "46",
      "year": "2017"
    },
    {
      "DOI": "10.1001/jamaoncol.2019.3616",
      "author": "J Tie",
      "doi-asserted-by": "publisher",
      "first-page": "1710",
      "journal-title": "JAMA Oncol",
      "key": "265_CR19",
      "unstructured": "Tie J, Cohen JD, Wang Y, Christie M, Simons K, Lee M, et al. Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer. JAMA Oncol. 2019;5:1710.",
      "volume": "5",
      "year": "2019"
    },
    {
      "DOI": "10.1126/scitranslmed.aaf6219",
      "author": "J Tie",
      "doi-asserted-by": "publisher",
      "first-page": "346ra92",
      "issue": "346",
      "journal-title": "Sci Transl Med",
      "key": "265_CR20",
      "unstructured": "Tie J, Wang Y, Tomasetti C, Li L, Springer S, Kinde I, et al. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci Transl Med. 2016;8(346):346ra92.",
      "volume": "8",
      "year": "2016"
    },
    {
      "DOI": "10.1002/gcc.22517",
      "author": "AL Volckmar",
      "doi-asserted-by": "publisher",
      "first-page": "123",
      "issue": "3",
      "journal-title": "Genes Chromosomes Cancer",
      "key": "265_CR21",
      "unstructured": "Volckmar AL, Sultmann H, Riediger A, Fioretos T, Schirmacher P, Endris V, et al. A field guide for cancer diagnostics using cell-free DNA: from principles to practice and clinical applications. Genes Chromosomes Cancer. 2018;57(3):123–39.",
      "volume": "57",
      "year": "2018"
    },
    {
      "DOI": "10.1200/JCO.2017.76.8671",
      "author": "JD Merker",
      "doi-asserted-by": "publisher",
      "first-page": "1631",
      "issue": "16",
      "journal-title": "J Clin Oncol",
      "key": "265_CR22",
      "unstructured": "Merker JD, Oxnard GR, Compton C, Diehn M, Hurley P, Lazar AJ, et al. Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists joint review. J Clin Oncol. 2018;36(16):1631–41.",
      "volume": "36",
      "year": "2018"
    },
    {
      "DOI": "10.18632/oncotarget.9453",
      "author": "F Cheng",
      "doi-asserted-by": "crossref",
      "first-page": "48832",
      "issue": "30",
      "journal-title": "Oncotarget.",
      "key": "265_CR23",
      "unstructured": "Cheng F, Su L, Qian C. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer. Oncotarget. 2016;7(30):48832–41.",
      "volume": "7",
      "year": "2016"
    },
    {
      "DOI": "10.3390/ijms19113356",
      "author": "V Vymetalkova",
      "doi-asserted-by": "publisher",
      "first-page": "3356",
      "issue": "11",
      "journal-title": "Int J Mol Sci",
      "key": "265_CR24",
      "unstructured": "Vymetalkova V, Cervena K, Bartu L, Vodicka P. Circulating cell-free DNA and colorectal cancer: a systematic review. Int J Mol Sci. 2018;19(11):3356.",
      "volume": "19",
      "year": "2018"
    },
    {
      "DOI": "10.1186/s12885-017-3693-7",
      "author": "IA Cree",
      "doi-asserted-by": "publisher",
      "first-page": "697",
      "issue": "1",
      "journal-title": "BMC Cancer",
      "key": "265_CR25",
      "unstructured": "Cree IA, Uttley L, Buckley Woods H, Kikuchi H, Reiman A, Harnan S, et al. The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review. BMC Cancer. 2017;17(1):697.",
      "volume": "17",
      "year": "2017"
    },
    {
      "DOI": "10.1038/cr.2017.121",
      "author": "W Li",
      "doi-asserted-by": "publisher",
      "first-page": "1243",
      "issue": "10",
      "journal-title": "Cell Res",
      "key": "265_CR26",
      "unstructured": "Li W, Zhang X, Lu X, You L, Song Y, Luo Z, et al. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers. Cell Res. 2017;27(10):1243–57.",
      "volume": "27",
      "year": "2017"
    },
    {
      "DOI": "10.1089/gtmb.2018.0173",
      "author": "J Chen",
      "doi-asserted-by": "publisher",
      "first-page": "264",
      "issue": "4",
      "journal-title": "Genet Test Mol Biomarkers",
      "key": "265_CR27",
      "unstructured": "Chen J, Chen J, He F, Huang Y, Lu S, Fan H, et al. Design of a targeted sequencing assay to detect rare mutations in circulating tumor DNA. Genet Test Mol Biomarkers. 2019;23(4):264–9.",
      "volume": "23",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.ab.2017.11.004",
      "author": "S Nikolaev",
      "doi-asserted-by": "publisher",
      "first-page": "34",
      "journal-title": "Anal Biochem",
      "key": "265_CR28",
      "unstructured": "Nikolaev S, Lemmens L, Koessler T, Blouin JL, Nouspikel T. Circulating tumoral DNA: preanalytical validation and quality control in a diagnostic laboratory. Anal Biochem. 2018;542:34–9.",
      "volume": "542",
      "year": "2018"
    },
    {
      "DOI": "10.1093/jnci/djx118",
      "doi-asserted-by": "crossref",
      "key": "265_CR29",
      "unstructured": "Wyatt AW, Annala M, Aggarwal R, Beja K, Feng F, Youngren J, et al. Concordance of circulating tumor DNA and matched metastatic tissue biopsy in prostate cancer. J Natl Cancer Inst. 2017;109(12)."
    },
    {
      "DOI": "10.1111/joim.12897",
      "author": "G Barbany",
      "doi-asserted-by": "crossref",
      "first-page": "118",
      "issue": "2",
      "journal-title": "J Intern Med",
      "key": "265_CR30",
      "unstructured": "Barbany G, Arthur C, Lieden A, Nordenskjold M, Rosenquist R, Tesi B, et al. Cell-free tumour DNA testing for early detection of cancer - a potential future tool. J Intern Med. 2019;286(2):118–36.",
      "volume": "286",
      "year": "2019"
    },
    {
      "DOI": "10.1101/gr.126417.111",
      "author": "CE Nestor",
      "doi-asserted-by": "publisher",
      "first-page": "467",
      "issue": "3",
      "journal-title": "Genome Res",
      "key": "265_CR31",
      "unstructured": "Nestor CE, Ottaviano R, Reddington J, Sproul D, Reinhardt D, Dunican D, et al. Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res. 2012;22(3):467–77.",
      "volume": "22",
      "year": "2012"
    },
    {
      "DOI": "10.1186/gb-2011-12-6-r54",
      "author": "H Stroud",
      "doi-asserted-by": "publisher",
      "first-page": "R54",
      "issue": "6",
      "journal-title": "Genome Biol",
      "key": "265_CR32",
      "unstructured": "Stroud H, Feng S, Morey Kinney S, Pradhan S, Jacobsen SE. 5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells. Genome Biol. 2011;12(6):R54.",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.1038/s41587-019-0041-2",
      "author": "Y Liu",
      "doi-asserted-by": "publisher",
      "first-page": "424",
      "issue": "4",
      "journal-title": "Nat Biotechnol",
      "key": "265_CR33",
      "unstructured": "Liu Y, Siejka-Zielinska P, Velikova G, Bi Y, Yuan F, Tomkova M, et al. Bisulfite-free direct detection of 5-methylcytosine and 5-hydroxymethylcytosine at base resolution. Nat Biotechnol. 2019;37(4):424–9.",
      "volume": "37",
      "year": "2019"
    },
    {
      "DOI": "10.1002/bies.201700010",
      "author": "Y Qing",
      "doi-asserted-by": "publisher",
      "first-page": "1700010",
      "issue": "5",
      "journal-title": "Bioessays",
      "key": "265_CR34",
      "unstructured": "Qing Y, Tian Z, Bi Y, Wang Y, Long J, Song CX, et al. Quantitation and mapping of the epigenetic marker 5-hydroxymethylcytosine. Bioessays. 2017;39(5):1700010.",
      "volume": "39",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.ygeno.2014.08.014",
      "author": "KL Nazor",
      "doi-asserted-by": "publisher",
      "first-page": "358",
      "issue": "5",
      "journal-title": "Genomics.",
      "key": "265_CR35",
      "unstructured": "Nazor KL, Boland MJ, Bibikova M, Klotzle B, Yu M, Glenn-Pratola VL, et al. Application of a low cost array-based technique - TAB-Array - for quantifying and mapping both 5mC and 5hmC at single base resolution in human pluripotent stem cells. Genomics. 2014;104(5):358–67.",
      "volume": "104",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nbt.3598",
      "author": "D Mooijman",
      "doi-asserted-by": "publisher",
      "first-page": "852",
      "issue": "8",
      "journal-title": "Nat Biotechnol",
      "key": "265_CR36",
      "unstructured": "Mooijman D, Dey SS, Boisset JC, Crosetto N, van Oudenaarden A. Single-cell 5hmC sequencing reveals chromosome-wide cell-to-cell variability and enables lineage reconstruction. Nat Biotechnol. 2016;34(8):852–6.",
      "volume": "34",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.cell.2012.11.022",
      "author": "M Mellen",
      "doi-asserted-by": "publisher",
      "first-page": "1417",
      "issue": "7",
      "journal-title": "Cell.",
      "key": "265_CR37",
      "unstructured": "Mellen M, Ayata P, Dewell S, Kriaucionis S, Heintz N. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell. 2012;151(7):1417–30.",
      "volume": "151",
      "year": "2012"
    },
    {
      "DOI": "10.1038/511524a",
      "author": "E Yong",
      "doi-asserted-by": "publisher",
      "first-page": "524",
      "issue": "7511",
      "journal-title": "Nature.",
      "key": "265_CR38",
      "unstructured": "Yong E. Cancer biomarkers: written in blood. Nature. 2014;511(7511):524–6.",
      "volume": "511",
      "year": "2014"
    },
    {
      "DOI": "10.1101/gr.211854.116",
      "author": "X Li",
      "doi-asserted-by": "publisher",
      "first-page": "1730",
      "issue": "12",
      "journal-title": "Genome Res",
      "key": "265_CR39",
      "unstructured": "Li X, Liu Y, Salz T, Hansen KD, Feinberg A. Whole-genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver. Genome Res. 2016;26(12):1730–41.",
      "volume": "26",
      "year": "2016"
    },
    {
      "DOI": "10.1002/hep.30211",
      "author": "RA Hlady",
      "doi-asserted-by": "publisher",
      "first-page": "639",
      "issue": "2",
      "journal-title": "Hepatology.",
      "key": "265_CR40",
      "unstructured": "Hlady RA, Sathyanarayan A, Thompson JJ, Zhou D, Wu Q, Pham K, et al. Integrating the epigenome to identify drivers of hepatocellular carcinoma. Hepatology. 2019;69(2):639–52.",
      "volume": "69",
      "year": "2019"
    },
    {
      "DOI": "10.1136/gutjnl-2019-318882",
      "author": "J Cai",
      "doi-asserted-by": "publisher",
      "first-page": "2195",
      "issue": "12",
      "journal-title": "Gut.",
      "key": "265_CR41",
      "unstructured": "Cai J, Chen L, Zhang Z, Zhang X, Lu X, Liu W, et al. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma. Gut. 2019;68(12):2195–205.",
      "volume": "68",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s13277-014-2900-2",
      "author": "ZR Dong",
      "doi-asserted-by": "publisher",
      "first-page": "2763",
      "issue": "4",
      "journal-title": "Tumour Biol",
      "key": "265_CR42",
      "unstructured": "Dong ZR, Zhang C, Cai JB, Zhang PF, Shi GM, Gao DM, et al. Role of 5-hydroxymethylcytosine level in diagnosis and prognosis prediction of intrahepatic cholangiocarcinoma. Tumour Biol. 2015;36(4):2763–71.",
      "volume": "36",
      "year": "2015"
    },
    {
      "DOI": "10.1111/cyt.12719",
      "author": "X Zhu",
      "doi-asserted-by": "publisher",
      "first-page": "492",
      "issue": "5",
      "journal-title": "Cytopathology.",
      "key": "265_CR43",
      "unstructured": "Zhu X, Dresser K, Chen BJ. Loss of 5-hydroxymethylcytosine immunohistochemical expression is a useful diagnostic aid for distinguishing hepatocellular carcinoma in cytology fine needle aspiration specimens. Cytopathology. 2019;30(5):492–8.",
      "volume": "30",
      "year": "2019"
    },
    {
      "DOI": "10.3892/ijo.2016.3535",
      "author": "C Ye",
      "doi-asserted-by": "publisher",
      "first-page": "589",
      "issue": "2",
      "journal-title": "Int J Oncol",
      "key": "265_CR44",
      "unstructured": "Ye C, Tao R, Cao Q, Zhu D, Wang Y, Wang J, et al. Whole-genome DNA methylation and hydroxymethylation profiling for HBV-related hepatocellular carcinoma. Int J Oncol. 2016;49(2):589–602.",
      "volume": "49",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.cell.2012.04.027",
      "author": "M Yu",
      "doi-asserted-by": "publisher",
      "first-page": "1368",
      "issue": "6",
      "journal-title": "Cell.",
      "key": "265_CR45",
      "unstructured": "Yu M, Hon GC, Szulwach KE, Song CX, Zhang L, Kim A, et al. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell. 2012;149(6):1368–80.",
      "volume": "149",
      "year": "2012"
    },
    {
      "DOI": "10.1186/s13072-017-0123-7",
      "author": "K Skvortsova",
      "doi-asserted-by": "publisher",
      "first-page": "16",
      "journal-title": "Epigenetics Chromatin",
      "key": "265_CR46",
      "unstructured": "Skvortsova K, Zotenko E, Luu PL, Gould CM, Nair SS, Clark SJ, et al. Comprehensive evaluation of genome-wide 5-hydroxymethylcytosine profiling approaches in human DNA. Epigenetics Chromatin. 2017;10:16.",
      "volume": "10",
      "year": "2017"
    },
    {
      "DOI": "10.1126/scitranslmed.3007094",
      "author": "C Bettegowda",
      "doi-asserted-by": "publisher",
      "first-page": "224ra24",
      "issue": "224",
      "journal-title": "Sci Transl Med",
      "key": "265_CR47",
      "unstructured": "Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6(224):224ra24.",
      "volume": "6",
      "year": "2014"
    },
    {
      "author": "O Brison",
      "first-page": "25",
      "issue": "1",
      "journal-title": "Biochim Biophys Acta",
      "key": "265_CR48",
      "unstructured": "Brison O. Gene amplification and tumor progression. Biochim Biophys Acta. 1993;1155(1):25–41.",
      "volume": "1155",
      "year": "1993"
    },
    {
      "DOI": "10.1111/cas.13505",
      "author": "H Nakagawa",
      "doi-asserted-by": "publisher",
      "first-page": "513",
      "issue": "3",
      "journal-title": "Cancer Sci",
      "key": "265_CR49",
      "unstructured": "Nakagawa H, Fujita M. Whole genome sequencing analysis for cancer genomics and precision medicine. Cancer Sci. 2018;109(3):513–22.",
      "volume": "109",
      "year": "2018"
    },
    {
      "DOI": "10.1038/nrg.2015.17",
      "author": "E Khurana",
      "doi-asserted-by": "publisher",
      "first-page": "93",
      "issue": "2",
      "journal-title": "Nat Rev Genet",
      "key": "265_CR50",
      "unstructured": "Khurana E, Fu Y, Chakravarty D, Demichelis F, Rubin MA, Gerstein M. Role of non-coding sequence variants in cancer. Nat Rev Genet. 2016;17(2):93–108.",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.15252/emmm.201506055",
      "author": "S Diederichs",
      "doi-asserted-by": "publisher",
      "first-page": "442",
      "issue": "5",
      "journal-title": "EMBO Mol Med",
      "key": "265_CR51",
      "unstructured": "Diederichs S, Bartsch L, Berkmann JC, Frose K, Heitmann J, Hoppe C, et al. The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations. EMBO Mol Med. 2016;8(5):442–57.",
      "volume": "8",
      "year": "2016"
    },
    {
      "DOI": "10.1038/sj.onc.1210176",
      "author": "KY Tai",
      "doi-asserted-by": "publisher",
      "first-page": "3989",
      "issue": "27",
      "journal-title": "Oncogene.",
      "key": "265_CR52",
      "unstructured": "Tai KY, Shiah SG, Shieh YS, Kao YR, Chi CY, Huang E, et al. DNA methylation and histone modification regulate silencing of epithelial cell adhesion molecule for tumor invasion and progression. Oncogene. 2007;26(27):3989–97.",
      "volume": "26",
      "year": "2007"
    },
    {
      "DOI": "10.1002/jcb.22256",
      "author": "TY Lu",
      "doi-asserted-by": "publisher",
      "first-page": "315",
      "issue": "1",
      "journal-title": "J Cell Biochem",
      "key": "265_CR53",
      "unstructured": "Lu TY, Kao CF, Lin CT, Huang DY, Chiu CY, Huang YS, et al. DNA methylation and histone modification regulate silencing of OPG during tumor progression. J Cell Biochem. 2009;108(1):315–25.",
      "volume": "108",
      "year": "2009"
    },
    {
      "DOI": "10.1186/gb-2014-15-6-r81",
      "author": "EL Putiri",
      "doi-asserted-by": "publisher",
      "first-page": "R81",
      "issue": "6",
      "journal-title": "Genome Biol",
      "key": "265_CR54",
      "unstructured": "Putiri EL, Tiedemann RL, Thompson JJ, Liu C, Ho T, Choi JH, et al. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells. Genome Biol. 2014;15(6):R81.",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nature14192",
      "author": "D Schubeler",
      "doi-asserted-by": "publisher",
      "first-page": "321",
      "issue": "7534",
      "journal-title": "Nature.",
      "key": "265_CR55",
      "unstructured": "Schubeler D. Function and information content of DNA methylation. Nature. 2015;517(7534):321–6.",
      "volume": "517",
      "year": "2015"
    },
    {
      "author": "L Feng",
      "first-page": "181",
      "journal-title": "Methods Mol Biol",
      "key": "265_CR56",
      "unstructured": "Feng L, Lou J. DNA methylation analysis. Methods Mol Biol. 1894;2019:181–227.",
      "volume": "2019",
      "year": "1894"
    },
    {
      "DOI": "10.1016/j.jid.2018.05.007",
      "author": "L Qiu",
      "doi-asserted-by": "publisher",
      "first-page": "2388",
      "issue": "11",
      "journal-title": "J Invest Dermatol",
      "key": "265_CR57",
      "unstructured": "Qiu L, Liu F, Yi S, Li X, Liu X, Xiao C, et al. Loss of 5-hydroxymethylcytosine is an epigenetic biomarker in cutaneous T-cell lymphoma. J Invest Dermatol. 2018;138(11):2388–97.",
      "volume": "138",
      "year": "2018"
    },
    {
      "DOI": "10.1182/blood.2019791475",
      "author": "CJ Lio",
      "doi-asserted-by": "publisher",
      "first-page": "1487",
      "issue": "18",
      "journal-title": "Blood.",
      "key": "265_CR58",
      "unstructured": "Lio CJ, Yuita H, Rao A. Dysregulation of the TET family of epigenetic regulators in lymphoid and myeloid malignancies. Blood. 2019;134(18):1487–97.",
      "volume": "134",
      "year": "2019"
    },
    {
      "DOI": "10.1080/15592294.2015.1062204",
      "author": "MG van der Wijst",
      "doi-asserted-by": "publisher",
      "first-page": "671",
      "issue": "8",
      "journal-title": "Epigenetics.",
      "key": "265_CR59",
      "unstructured": "van der Wijst MG, Venkiteswaran M, Chen H, Xu GL, Plosch T, Rots MG. Local chromatin microenvironment determines DNMT activity: from DNA methyltransferase to DNA demethylase or DNA dehydroxymethylase. Epigenetics. 2015;10(8):671–6.",
      "volume": "10",
      "year": "2015"
    },
    {
      "DOI": "10.1074/jbc.C112.406975",
      "author": "CC Chen",
      "doi-asserted-by": "publisher",
      "first-page": "33116",
      "issue": "40",
      "journal-title": "J Biol Chem",
      "key": "265_CR60",
      "unstructured": "Chen CC, Wang KY, Shen CK. The mammalian de novo DNA methyltransferases DNMT3A and DNMT3B are also DNA 5-hydroxymethylcytosine dehydroxymethylases. J Biol Chem. 2012;287(40):33116–21.",
      "volume": "287",
      "year": "2012"
    },
    {
      "DOI": "10.1159/000438499",
      "author": "A Kanazawa",
      "doi-asserted-by": "publisher",
      "first-page": "691",
      "issue": "5",
      "journal-title": "Dig Dis",
      "key": "265_CR61",
      "unstructured": "Kanazawa A, Tsukamoto T, Shimizu S, Yamamoto S, Murata A, Kubo S. Laparoscopic hepatectomy for liver cancer. Dig Dis. 2015;33(5):691–8.",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1186/s13072-016-0070-8",
      "author": "X Tekpli",
      "doi-asserted-by": "publisher",
      "first-page": "21",
      "journal-title": "Epigenetics Chromatin",
      "key": "265_CR62",
      "unstructured": "Tekpli X, Urbanucci A, Hashim A, Vagbo CB, Lyle R, Kringen MK, et al. Changes of 5-hydroxymethylcytosine distribution during myeloid and lymphoid differentiation of CD34+ cells. Epigenetics Chromatin. 2016;9:21.",
      "volume": "9",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s13402-016-0295-3",
      "author": "X Tekpli",
      "doi-asserted-by": "publisher",
      "first-page": "583",
      "issue": "6",
      "journal-title": "Cell Oncol (Dordr)",
      "key": "265_CR63",
      "unstructured": "Tekpli X, Skaug V, Baera R, Phillips DH, Haugen A, Mollerup S. Estrogen receptor expression and gene promoter methylation in non-small cell lung cancer - a short report. Cell Oncol (Dordr). 2016;39(6):583–9.",
      "volume": "39",
      "year": "2016"
    },
    {
      "DOI": "10.18632/oncotarget.6039",
      "author": "F Neri",
      "doi-asserted-by": "publisher",
      "first-page": "34049",
      "issue": "33",
      "journal-title": "Oncotarget.",
      "key": "265_CR64",
      "unstructured": "Neri F, Incarnato D, Oliviero S. DNA methylation and demethylation dynamics. Oncotarget. 2015;6(33):34049–50.",
      "volume": "6",
      "year": "2015"
    },
    {
      "DOI": "10.1038/onc.2014.356",
      "author": "F Neri",
      "doi-asserted-by": "publisher",
      "first-page": "4168",
      "issue": "32",
      "journal-title": "Oncogene.",
      "key": "265_CR65",
      "unstructured": "Neri F, Dettori D, Incarnato D, Krepelova A, Rapelli S, Maldotti M, et al. TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway. Oncogene. 2015;34(32):4168–76.",
      "volume": "34",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nature14248",
      "author": "A Kundaje",
      "doi-asserted-by": "publisher",
      "first-page": "317",
      "issue": "7539",
      "journal-title": "Nature.",
      "key": "265_CR66",
      "unstructured": "Kundaje A, Meuleman W, Ernst J, Bilenky M, Yen A, Heravi-Moussavi A, et al. Integrative analysis of 111 reference human epigenomes. Nature. 2015;518(7539):317–30.",
      "volume": "518",
      "year": "2015"
    },
    {
      "DOI": "10.1056/NEJMoa1802357",
      "author": "AMM Eggermont",
      "doi-asserted-by": "publisher",
      "first-page": "1789",
      "issue": "19",
      "journal-title": "N Engl J Med",
      "key": "265_CR67",
      "unstructured": "Eggermont AMM, Blank CU, Mandala M, Long GV, Atkinson V, Dalle S, et al. Adjuvant pembrolizumab versus placebo in resected stage III melanoma. N Engl J Med. 2018;378(19):1789–801.",
      "volume": "378",
      "year": "2018"
    },
    {
      "DOI": "10.1038/jid.2010.149",
      "author": "BE Gould Rothberg",
      "doi-asserted-by": "publisher",
      "first-page": "1971",
      "issue": "8",
      "journal-title": "J Invest Dermatol.",
      "key": "265_CR68",
      "unstructured": "Gould Rothberg BE, Rimm DL. Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma. J Invest Dermatol. 2010;130(8):1971–87.",
      "volume": "130",
      "year": "2010"
    },
    {
      "DOI": "10.2217/mmt.15.15",
      "author": "O Yelamos",
      "doi-asserted-by": "publisher",
      "first-page": "217",
      "issue": "3",
      "journal-title": "Melanoma Manag",
      "key": "265_CR69",
      "unstructured": "Yelamos O, Gerami P. Predicting the outcome of melanoma: can we tell the future of a patient’s melanoma? Melanoma Manag. 2015;2(3):217–24.",
      "volume": "2",
      "year": "2015"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-13-3316",
      "author": "P Gerami",
      "doi-asserted-by": "publisher",
      "first-page": "175",
      "issue": "1",
      "journal-title": "Clin Cancer Res",
      "key": "265_CR70",
      "unstructured": "Gerami P, Cook RW, Wilkinson J, Russell MC, Dhillon N, Amaria RN, et al. Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma. Clin Cancer Res. 2015;21(1):175–83.",
      "volume": "21",
      "year": "2015"
    },
    {
      "DOI": "10.1093/nar/gkr120",
      "author": "SG Jin",
      "doi-asserted-by": "publisher",
      "first-page": "5015",
      "issue": "12",
      "journal-title": "Nucleic Acids Res",
      "key": "265_CR71",
      "unstructured": "Jin SG, Wu X, Li AX, Pfeifer GP. Genomic mapping of 5-hydroxymethylcytosine in the human brain. Nucleic Acids Res. 2011;39(12):5015–24.",
      "volume": "39",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nature10443",
      "author": "TP Gu",
      "doi-asserted-by": "publisher",
      "first-page": "606",
      "issue": "7366",
      "journal-title": "Nature.",
      "key": "265_CR72",
      "unstructured": "Gu TP, Guo F, Yang H, Wu HP, Xu GF, Liu W, et al. The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature. 2011;477(7366):606–10.",
      "volume": "477",
      "year": "2011"
    },
    {
      "DOI": "10.1126/science.1170116",
      "author": "M Tahiliani",
      "doi-asserted-by": "publisher",
      "first-page": "930",
      "issue": "5929",
      "journal-title": "Science.",
      "key": "265_CR73",
      "unstructured": "Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. 2009;324(5929):930–5.",
      "volume": "324",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.stem.2011.08.007",
      "author": "L Cimmino",
      "doi-asserted-by": "publisher",
      "first-page": "193",
      "issue": "3",
      "journal-title": "Cell Stem Cell",
      "key": "265_CR74",
      "unstructured": "Cimmino L, Abdel-Wahab O, Levine RL, Aifantis I. TET family proteins and their role in stem cell differentiation and transformation. Cell Stem Cell. 2011;9(3):193–204.",
      "volume": "9",
      "year": "2011"
    },
    {
      "DOI": "10.1097/CMR.0b013e32835f9bd4",
      "author": "T Gambichler",
      "doi-asserted-by": "publisher",
      "first-page": "218",
      "issue": "3",
      "journal-title": "Melanoma Res",
      "key": "265_CR75",
      "unstructured": "Gambichler T, Sand M, Skrygan M. Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma. Melanoma Res. 2013;23(3):218–20.",
      "volume": "23",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.jdermsci.2013.09.008",
      "author": "R Uchiyama",
      "doi-asserted-by": "publisher",
      "first-page": "161",
      "issue": "2",
      "journal-title": "J Dermatol Sci",
      "key": "265_CR76",
      "unstructured": "Uchiyama R, Uhara H, Uchiyama A, Ogawa E, Takazawa Y, Ashida A, et al. 5-Hydroxymethylcytosine as a useful marker to differentiate between malignant melanomas and benign melanocytic nevi. J Dermatol Sci. 2014;73(2):161–3.",
      "volume": "73",
      "year": "2014"
    },
    {
      "DOI": "10.1111/jdv.12614",
      "author": "Y Mikoshiba",
      "doi-asserted-by": "publisher",
      "first-page": "130",
      "issue": "1",
      "journal-title": "J Eur Acad Dermatol Venereol",
      "key": "265_CR77",
      "unstructured": "Mikoshiba Y, Ogawa E, Uchiyama R, Uchiyama A, Uhara H, Okuyama R. 5-Hydroxymethylcytosine is a useful marker to differentiate between dermatofibrosarcoma protuberans and dermatofibroma. J Eur Acad Dermatol Venereol. 2016;30(1):130–1.",
      "volume": "30",
      "year": "2016"
    },
    {
      "DOI": "10.1093/carcin/bgu140",
      "author": "F Song",
      "doi-asserted-by": "publisher",
      "first-page": "2097",
      "issue": "9",
      "journal-title": "Carcinogenesis.",
      "key": "265_CR78",
      "unstructured": "Song F, Amos CI, Lee JE, Lian CG, Fang S, Liu H, et al. Identification of a melanoma susceptibility locus and somatic mutation in TET2. Carcinogenesis. 2014;35(9):2097–101.",
      "volume": "35",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.ajpath.2010.12.011",
      "author": "T Shibata",
      "doi-asserted-by": "publisher",
      "first-page": "1395",
      "issue": "3",
      "journal-title": "Am J Pathol",
      "key": "265_CR79",
      "unstructured": "Shibata T, Kokubu A, Miyamoto M, Sasajima Y, Yamazaki N. Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation. Am J Pathol. 2011;178(3):1395–402.",
      "volume": "178",
      "year": "2011"
    },
    {
      "DOI": "10.1371/journal.pone.0146302",
      "author": "E Munari",
      "doi-asserted-by": "publisher",
      "issue": "1",
      "journal-title": "PLoS One",
      "key": "265_CR80",
      "unstructured": "Munari E, Chaux A, Vaghasia AM, Taheri D, Karram S, Bezerra SM, et al. Global 5-hydroxymethylcytosine levels are profoundly reduced in multiple genitourinary malignancies. PLoS One. 2016;11(1):e0146302.",
      "volume": "11",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nature09303",
      "author": "S Ito",
      "doi-asserted-by": "publisher",
      "first-page": "1129",
      "issue": "7310",
      "journal-title": "Nature.",
      "key": "265_CR81",
      "unstructured": "Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature. 2010;466(7310):1129–33.",
      "volume": "466",
      "year": "2010"
    },
    {
      "DOI": "10.1097/DAD.0b013e31828a2ec5",
      "author": "O Abbas",
      "doi-asserted-by": "publisher",
      "first-page": "363",
      "issue": "5",
      "journal-title": "Am J Dermatopathol",
      "key": "265_CR82",
      "unstructured": "Abbas O, Miller DD, Bhawan J. Cutaneous malignant melanoma: update on diagnostic and prognostic biomarkers. Am J Dermatopathol. 2014;36(5):363–79.",
      "volume": "36",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.breast.2012.07.004",
      "author": "SG Wu",
      "doi-asserted-by": "publisher",
      "first-page": "657",
      "issue": "5",
      "journal-title": "Breast.",
      "key": "265_CR83",
      "unstructured": "Wu SG, He ZY, Li Q, Li FY, Lin Q, Lin HX, et al. Predictive value of breast cancer molecular subtypes in Chinese patients with four or more positive nodes after postmastectomy radiotherapy. Breast. 2012;21(5):657–61.",
      "volume": "21",
      "year": "2012"
    },
    {
      "DOI": "10.1200/JCO.2011.36.1105",
      "author": "ND Arvold",
      "doi-asserted-by": "publisher",
      "first-page": "3885",
      "issue": "29",
      "journal-title": "J Clin Oncol",
      "key": "265_CR84",
      "unstructured": "Arvold ND, Taghian AG, Niemierko A, Abi Raad RF, Sreedhara M, Nguyen PL, et al. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol. 2011;29(29):3885–91.",
      "volume": "29",
      "year": "2011"
    },
    {
      "DOI": "10.1038/onc.2012.67",
      "author": "H Yang",
      "doi-asserted-by": "publisher",
      "first-page": "663",
      "issue": "5",
      "journal-title": "Oncogene.",
      "key": "265_CR85",
      "unstructured": "Yang H, Liu Y, Bai F, Zhang JY, Ma SH, Liu J, et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene. 2013;32(5):663–9.",
      "volume": "32",
      "year": "2013"
    },
    {
      "DOI": "10.1038/sj.leu.2402834",
      "author": "RB Lorsbach",
      "doi-asserted-by": "publisher",
      "first-page": "637",
      "issue": "3",
      "journal-title": "Leukemia.",
      "key": "265_CR86",
      "unstructured": "Lorsbach RB, Moore J, Mathew S, Raimondi SC, Mukatira ST, Downing JR. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia. 2003;17(3):637–41.",
      "volume": "17",
      "year": "2003"
    },
    {
      "DOI": "10.1038/leu.2009.59",
      "author": "A Tefferi",
      "doi-asserted-by": "publisher",
      "first-page": "1343",
      "issue": "7",
      "journal-title": "Leukemia",
      "key": "265_CR87",
      "unstructured": "Tefferi A, Lim KH, Abdel-Wahab O, Lasho TL, Patel J, Patnaik MM, et al. Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML. Leukemia. 2009;23(7):1343–5.",
      "volume": "23",
      "year": "2009"
    },
    {
      "DOI": "10.1182/blood-2009-03-210039",
      "author": "O Abdel-Wahab",
      "doi-asserted-by": "publisher",
      "first-page": "144",
      "issue": "1",
      "journal-title": "Blood.",
      "key": "265_CR88",
      "unstructured": "Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, Wadleigh M, et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood. 2009;114(1):144–7.",
      "volume": "114",
      "year": "2009"
    },
    {
      "DOI": "10.1371/journal.pone.0062828",
      "author": "C Liu",
      "doi-asserted-by": "publisher",
      "issue": "5",
      "journal-title": "PLoS One",
      "key": "265_CR89",
      "unstructured": "Liu C, Liu L, Chen X, Shen J, Shan J, Xu Y, et al. Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1. PLoS One. 2013;8(5):e62828.",
      "volume": "8",
      "year": "2013"
    },
    {
      "DOI": "10.1371/journal.pone.0133896",
      "author": "L Yang",
      "doi-asserted-by": "publisher",
      "issue": "7",
      "journal-title": "PLoS One",
      "key": "265_CR90",
      "unstructured": "Yang L, Yu SJ, Hong Q, Yang Y, Shao ZM. Reduced expression of TET1, TET2, TET3 and TDG mRNAs are associated with poor prognosis of patients with early breast cancer. PLoS One. 2015;10(7):e0133896.",
      "volume": "10",
      "year": "2015"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-14-3208",
      "author": "MZ Wu",
      "doi-asserted-by": "publisher",
      "first-page": "3912",
      "issue": "18",
      "journal-title": "Cancer Res",
      "key": "265_CR91",
      "unstructured": "Wu MZ, Chen SF, Nieh S, Benner C, Ger LP, Jan CI, et al. Hypoxia drives breast tumor malignancy through a TET-TNFalpha-p38-MAPK signaling axis. Cancer Res. 2015;75(18):3912–24.",
      "volume": "75",
      "year": "2015"
    },
    {
      "DOI": "10.1038/leu.2009.37",
      "author": "A Tefferi",
      "doi-asserted-by": "publisher",
      "first-page": "900",
      "issue": "5",
      "journal-title": "Leukemia.",
      "key": "265_CR92",
      "unstructured": "Tefferi A, Levine RL, Lim KH, Abdel-Wahab O, Lasho TL, Patel J, et al. Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates. Leukemia. 2009;23(5):900–4.",
      "volume": "23",
      "year": "2009"
    },
    {
      "DOI": "10.3322/CA.2007.0010",
      "author": "A Jemal",
      "doi-asserted-by": "publisher",
      "first-page": "71",
      "issue": "2",
      "journal-title": "CA Cancer J Clin",
      "key": "265_CR93",
      "unstructured": "Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71–96.",
      "volume": "58",
      "year": "2008"
    },
    {
      "DOI": "10.1038/nrd891",
      "author": "EF Petricoin",
      "doi-asserted-by": "publisher",
      "first-page": "683",
      "issue": "9",
      "journal-title": "Nat Rev Drug Discov",
      "key": "265_CR94",
      "unstructured": "Petricoin EF, Zoon KC, Kohn EC, Barrett JC, Liotta LA. Clinical proteomics: translating benchside promise into bedside reality. Nat Rev Drug Discov. 2002;1(9):683–95.",
      "volume": "1",
      "year": "2002"
    },
    {
      "DOI": "10.1007/s00345-007-0234-z",
      "author": "E Schiffer",
      "doi-asserted-by": "publisher",
      "first-page": "67",
      "issue": "1",
      "journal-title": "World J Urol",
      "key": "265_CR95",
      "unstructured": "Schiffer E, Mischak H, Theodorescu D, Vlahou A. Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform. World J Urol. 2008;26(1):67–74.",
      "volume": "26",
      "year": "2008"
    },
    {
      "DOI": "10.1097/MOU.0b013e32830b86d1",
      "author": "M Lodde",
      "doi-asserted-by": "publisher",
      "first-page": "499",
      "issue": "5",
      "journal-title": "Curr Opin Urol",
      "key": "265_CR96",
      "unstructured": "Lodde M, Fradet Y. The detection of genetic markers of bladder cancer in urine and serum. Curr Opin Urol. 2008;18(5):499–503.",
      "volume": "18",
      "year": "2008"
    },
    {
      "DOI": "10.1111/j.1442-2042.2008.02225.x",
      "author": "OP Vrooman",
      "doi-asserted-by": "publisher",
      "first-page": "234",
      "issue": "3",
      "journal-title": "Int J Urol",
      "key": "265_CR97",
      "unstructured": "Vrooman OP, Witjes JA. Molecular markers for detection, surveillance and prognostication of bladder cancer. Int J Urol. 2009;16(3):234–43.",
      "volume": "16",
      "year": "2009"
    },
    {
      "DOI": "10.1002/jbmr.2711",
      "author": "SE Taylor",
      "doi-asserted-by": "publisher",
      "first-page": "524",
      "issue": "3",
      "journal-title": "J Bone Miner Res",
      "key": "265_CR98",
      "unstructured": "Taylor SE, Li YH, Smeriglio P, Rath M, Wong WH, Bhutani N. Stable 5-hydroxymethylcytosine (5hmC) acquisition marks gene activation during chondrogenic differentiation. J Bone Miner Res. 2016;31(3):524–34.",
      "volume": "31",
      "year": "2016"
    },
    {
      "DOI": "10.1111/j.1442-2042.2008.02143.x",
      "author": "YK Kim",
      "doi-asserted-by": "publisher",
      "first-page": "17",
      "issue": "1",
      "journal-title": "Int J Urol",
      "key": "265_CR99",
      "unstructured": "Kim YK, Kim WJ. Epigenetic markers as promising prognosticators for bladder cancer. Int J Urol. 2009;16(1):17–22.",
      "volume": "16",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.urolonc.2008.12.008",
      "author": "HH Lin",
      "doi-asserted-by": "publisher",
      "first-page": "597",
      "issue": "6",
      "journal-title": "Urol Oncol",
      "key": "265_CR100",
      "unstructured": "Lin HH, Ke HL, Huang SP, Wu WJ, Chen YK, Chang LL. Increase sensitivity in detecting superficial, low grade bladder cancer by combination analysis of hypermethylation of E-cadherin, p16, p14, RASSF1A genes in urine. Urol Oncol. 2010;28(6):597–602.",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1182/blood-2009-02-205690",
      "author": "AM Jankowska",
      "doi-asserted-by": "publisher",
      "first-page": "6403",
      "issue": "25",
      "journal-title": "Blood.",
      "key": "265_CR101",
      "unstructured": "Jankowska AM, Szpurka H, Tiu RV, Makishima H, Afable M, Huh J, et al. Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms. Blood. 2009;113(25):6403–10.",
      "volume": "113",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.cell.2012.07.033",
      "author": "CG Lian",
      "doi-asserted-by": "publisher",
      "first-page": "1135",
      "issue": "6",
      "journal-title": "Cell.",
      "key": "265_CR102",
      "unstructured": "Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell. 2012;150(6):1135–46.",
      "volume": "150",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s00702-014-1346-4",
      "author": "TF Kraus",
      "doi-asserted-by": "publisher",
      "first-page": "1035",
      "issue": "7",
      "journal-title": "J Neural Transm (Vienna)",
      "key": "265_CR103",
      "unstructured": "Kraus TF, Guibourt V, Kretzschmar HA. 5-Hydroxymethylcytosine, the “Sixth Base”, during brain development and ageing. J Neural Transm (Vienna). 2015;122(7):1035–43.",
      "volume": "122",
      "year": "2015"
    },
    {
      "author": "SR Rustad",
      "first-page": "51",
      "journal-title": "Curr Top Behav Neurosci",
      "key": "265_CR104",
      "unstructured": "Rustad SR, Papale LA, Alisch RS. DNA methylation and hydroxymethylation and behavior. Curr Top Behav Neurosci. 2019;42:51–82.",
      "volume": "42",
      "year": "2019"
    },
    {
      "DOI": "10.1093/eep/dvw016",
      "author": "LM Hack",
      "doi-asserted-by": "publisher",
      "first-page": "dvw016",
      "issue": "3",
      "journal-title": "Environ Epigenet",
      "key": "265_CR105",
      "unstructured": "Hack LM, Dick ALW, Provencal N. Epigenetic mechanisms involved in the effects of stress exposure: focus on 5-hydroxymethylcytosine. Environ Epigenet. 2016;2(3):dvw016.",
      "volume": "2",
      "year": "2016"
    },
    {
      "DOI": "10.1177/2516865720910155",
      "doi-asserted-by": "publisher",
      "key": "265_CR106",
      "unstructured": "Zhu T, Brown AP, Ji H. The emerging role of ten-eleven translocation 1 in epigenetic responses to environmental exposures. Epigenet Insights. 2020;13. https://doi.org/10.1177/2516865720910155."
    },
    {
      "DOI": "10.1093/nar/gkt232",
      "author": "JP Thomson",
      "doi-asserted-by": "publisher",
      "first-page": "5639",
      "issue": "11",
      "journal-title": "Nucleic Acids Res",
      "key": "265_CR107",
      "unstructured": "Thomson JP, Hunter JM, Lempiainen H, Muller A, Terranova R, Moggs JG, et al. Dynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver. Nucleic Acids Res. 2013;41(11):5639–54.",
      "volume": "41",
      "year": "2013"
    },
    {
      "DOI": "10.1186/s13148-016-0195-4",
      "author": "SN Kamdar",
      "doi-asserted-by": "publisher",
      "first-page": "32",
      "journal-title": "Clin Epigenetics",
      "key": "265_CR108",
      "unstructured": "Kamdar SN, Ho LT, Kron KJ, Isserlin R, van der Kwast T, Zlotta AR, et al. Dynamic interplay between locus-specific DNA methylation and hydroxymethylation regulates distinct biological pathways in prostate carcinogenesis. Clin Epigenetics. 2016;8:32.",
      "volume": "8",
      "year": "2016"
    },
    {
      "DOI": "10.1186/s13148-017-0368-9",
      "author": "N Gilat",
      "doi-asserted-by": "publisher",
      "first-page": "70",
      "journal-title": "Clin Epigenetics",
      "key": "265_CR109",
      "unstructured": "Gilat N, Tabachnik T, Shwartz A, Shahal T, Torchinsky D, Michaeli Y, et al. Single-molecule quantification of 5-hydroxymethylcytosine for diagnosis of blood and colon cancers. Clin Epigenetics. 2017;9:70.",
      "volume": "9",
      "year": "2017"
    }
  ],
  "reference-count": 109,
  "references-count": 109,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-020-00265-5"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Hydroxymethylation and tumors: can 5-hydroxymethylation be used as a marker for tumor diagnosis and treatment?"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "14"
}